See more : TransAKT Ltd. (TAKD) Income Statement Analysis – Financial Results
Complete financial analysis of NewAge, Inc. (NBEV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NewAge, Inc., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- USHG Acquisition Corp. (HUGS-UN) Income Statement Analysis – Financial Results
- Total Helium Ltd. (TOH.V) Income Statement Analysis – Financial Results
- Nuvama Wealth Management Limited (NUVAMA.BO) Income Statement Analysis – Financial Results
- Villars Holding S.A. (0QLJ.L) Income Statement Analysis – Financial Results
- Maniker.Co.,Ltd (027740.KS) Income Statement Analysis – Financial Results
NewAge, Inc. (NBEV)
About NewAge, Inc.
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 279.47M | 253.71M | 52.16M | 52.19M | 25.30M | 0.00 | 1.04M | 968.94K |
| Cost of Revenue | 101.98M | 101.00M | 42.87M | 39.79M | 19.51M | 0.00 | 879.46K | 684.59K |
| Gross Profit | 177.49M | 152.71M | 9.30M | 12.40M | 5.80M | 0.00 | 164.19K | 284.35K |
| Gross Profit Ratio | 63.51% | 60.19% | 17.82% | 23.76% | 22.91% | 0.00% | 15.73% | 29.35% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 113.21M | 0.00 | 20.29M | 14.61M | 7.84M | 0.00 | 1.28M | 415.09K |
| Selling & Marketing | 0.00 | 0.00 | 2.78M | 3.84M | 1.58M | 0.00 | 155.98K | 174.01K |
| SG&A | 113.21M | 0.00 | 23.07M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Other Expenses | 99.13M | 199.33M | 2.31M | 668.05M | 1.47M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 212.34M | 199.33M | 25.38M | 18.45M | 9.42M | 0.00 | 1.44M | 589.11K |
| Cost & Expenses | 314.32M | 300.33M | 68.24M | 58.24M | 28.93M | 0.00 | 2.32M | 1.27M |
| Interest Income | 0.00 | -227.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.38M | 3.90M | 1.07M | 228.04K | 299.08K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 8.93M | 8.76M | 2.31M | 1.61M | 523.75K | 77.82K | 169.40K | 103.21K |
| EBITDA | -29.93M | -64.50M | -17.68M | -1.70M | -2.81M | 0.00 | -1.08M | -227.14K |
| EBITDA Ratio | -10.71% | -25.42% | -33.90% | -3.26% | -11.11% | 0.00% | -103.52% | -23.44% |
| Operating Income | -34.85M | -80.00M | -19.37M | -6.05M | -3.63M | 0.00 | -1.28M | -304.75K |
| Operating Income Ratio | -12.47% | -31.53% | -37.14% | -11.59% | -14.33% | 0.00% | -122.27% | -31.45% |
| Total Other Income/Expenses | -2.60M | -98.17M | -1.69M | 2.51M | -6.32K | 0.00 | 26.32K | -25.59K |
| Income Before Tax | -37.45M | -77.17M | -21.06M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Income Before Tax Ratio | -13.40% | -30.42% | -40.38% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| Income Tax Expense | -1.90M | 12.67M | -8.93M | 2.74M | 292.76K | 0.00 | 26.32K | -25.59K |
| Net Income | -39.34M | -89.84M | -12.14M | -3.54M | -3.63M | 0.00 | -1.25M | -330.34K |
| Net Income Ratio | -14.08% | -35.41% | -23.26% | -6.78% | -14.36% | 0.00% | -119.75% | -34.09% |
| EPS | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| EPS Diluted | -0.41 | -1.16 | -0.26 | -0.12 | -0.19 | 0.00 | -0.10 | -0.03 |
| Weighted Avg Shares Out | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
| Weighted Avg Shares Out (Dil) | 96.35M | 77.25M | 46.45M | 30.62M | 18.89M | 18.89M | 12.39M | 12.56M |
NewAge Announces $58 Million Private Placement
5 Sizzling Stocks to Buy Trading Under $10 With Massive Upside Potential
NewAge and ARIIX Close Merger
NewAge's (NBEV) CEO Brent Willis on Q3 2020 Results - Earnings Call Transcript
Newage Announces Third Quarter Financial Results
NewAge Announces Timing for Third Quarter 2020 Financial Results and Conference Call
Aspen Technology (NASDAQ:AZPN) Downgraded to “Hold” at Zacks Investment Research
Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Aspen Aerogels: The New Patent Is A Game-Changer (NYSE:ASPN)
Pandemic Home Buyers Drive Aspen’s New Gold Rush
Source: https://incomestatements.info
Category: Stock Reports